Search - tctmd.com

Displaying 281 - 290 of 290

Sort: Relevancy | Date

News Daily News

Left Atrial Appendage Morphology May Help Predict Stroke Risk in A-fib Patients

July 31, 2012

News Industry News

Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device

July 02, 2012

News Industry News

Key Clinical Data for St. Jude Medical’s Structural Heart Technologies Revealed at EuroPCR

May 16, 2012

News Industry News

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

May 11, 2012

News Daily News

Lack of Complete Seal with Watchman Device Common, But No Cause for Alarm

Jason Kahn

March 05, 2012

News Daily News

La Falta de Sellado Completo con el Dispositivo Watchman es Común pero No hay Razón para la Alarma

Jason Kahn

March 05, 2012

News Industry News

Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America

November 15, 2011

News Industry News

Boston Scientific Announces Schedule of Events at TCT Scientific Symposium

November 01, 2011

News Industry News

Favorable Clinical Study Results Reported With Dual Anti-Platelet Therapy After LAA Closure With WATCHMAN® Device

May 18, 2011

News Daily News

Ongoing Experience Improves Safety for LAA Closure with Watchman Device

Caitlin E. Cox

January 20, 2011

Advertisement

Left Atrial Appendage Morphology May Help Predict Stroke Risk in A-fib Patients

Boston Scientific Completes Patient Enrollment in PREVAIL Study for First-in-Class WATCHMAN Device

Key Clinical Data for St. Jude Medical’s Structural Heart Technologies Revealed at EuroPCR

Study of First-in-Class WATCHMAN® Device Shows 75 Percent Reduction in Stroke Risk in Patients with Atrial Fibrillation Not Eligible for Oral Anticoagulation Therapy

Lack of Complete Seal with Watchman Device Common, But No Cause for Alarm

La Falta de Sellado Completo con el Dispositivo Watchman es Común pero No hay Razón para la Alarma

Boston Scientific's WATCHMAN® Device Implanted in First Patients in Latin America

Boston Scientific Announces Schedule of Events at TCT Scientific Symposium

Favorable Clinical Study Results Reported With Dual Anti-Platelet Therapy After LAA Closure With WATCHMAN® Device

Ongoing Experience Improves Safety for LAA Closure with Watchman Device

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content